Articles

Control charts are an accurate way of measuring disparity in endophthalmitis following phacoemulsification, according to a study published online ahead of print by Eye.

Paediatric subjects who require frequent steroid therapy are at an increased risk of developing amblyopia due to cataracts, according to a study published online ahead of print by Pediatrics International, the official English language publication of the Japan Pediatric Society.

The protein/peptide patterns in the aqueous humour of primary open-angle glaucoma (POAG) subjects differs significantly from that of control subjects, according to a study published in the August 2008 issue of Molecular Vision.

Defocus curve measurement of subjective amplitude of accommodation (AoA) is not affected by non-randomized letter sequences in presbyopic subjects, according to results of a study published in the August 2008 issue of the Journal of Cataract & Refractive Surgery.

Patients with glaucoma are not at an increased risk of developing systemic vascular disease, according to a study published in the August 2008 issue of the Acta Ophthalmologica.

The incidence of endophthalmitis is independent of whether prophylactic antibiotics are administered in conjunction with Avastin (bevacizumab) injections, according to results of a study published in the February 2008 issue of Spektrum der Augenheilkunde.

The Phase IIb clinical trial of I-vation TA (Merck & Co), an intravitreal injection incorporating triamcinolone acetonide (TA) for the treatment of diabetic macular oedema (DME), has been suspended.

Early unilateral cataract surgery in infants can produce good visual outcomes even if patching is discontinued, according to a study in the August 2008 issue of the Archives of Ophthalmology.

A genetic mutation that is associated with recessive cone-rod dystrophy in dachshunds may play the same role in humans, according to a study in the August 2008 issue of Genome Research.

IBI-20089, a drug candidate for the treatment of cystoid macular oedema (CME), has completed patient enrollment for initial clinical testing, according to the drug's manufacturer, Icon Bioscience Inc (IBI).

Three-day application of levofloxacin in the presence of polyvinyl alcohol-iodine or povidone iodine offers the best infection control in phaco patients, according to a study published in the May 2008 issue of the Japanese Journal of Ophthalmology.

Sufferers of retinitis pigmentosa (RP) have a lower concentration of vascular endothelial growth factor A (VEGF-A) in the aqueous humour than non-sufferers, according to results of a study published in the August 2008 issue of Investigative Ophthalmology and Visual Science.

Implanting a multifocal intraocular lens (IOL) into the non-dominant eye is a promising treatment for presbyopic emmetropic patients, according to a study published in the February 2008 issue of Spektrum der Augenheilkunde.

Glaucoma treatment can, in certain metrics, improve quality of vision, according to a study published in the August 2008 issue of Eye.

Erythropoietin (EPO) could be responsible for the development of diabetic retinopathy, according to a study published in the August 2008 issue of Eye.

Patients with thicker corneas are less likely to progress to primary open angle glaucoma (POAG) from ocular hypertension (OHT), according to a study published in the June 2008 issue of Contact Lens and Anterior Eye.

Genetic factors explain up to 74% of the variability in intraocular pressure (IOP) levels, according to a study published in the July 2008 issue of the British Journal of Ophthalmology.

The incidence of sterile endophthalmitis occurring subsequent to an intravitreal injection of triamcinolone acetonide (IVTA) is increasing, according to a study published in the August 2008 issue of the British Journal of Ophthalmology.

Focal/grid photocoagulation is more effective than intravitreal injections of preservative-free triamcinolone for the treatment of diabetic macular oedema (DME), according to a study published in the July 2008 issue of Ophthalmology.

Pfizer has begun dosing subjects in its Phase II trial for PF-4523655, an experimental treatment for Diabetic Macular Oedema (DME) developed in partnership with Quark Pharmaceuticals Inc.

The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid.

Reading may be a risk factor for childhood myopia, according to a study published in the August 2008 issue of the British Journal of Ophthalmology.

Spectacles with a biotic telescope embedded within the lens promise to make everyday life easier for individuals with low vision, according to a paper published in the May/June 2008 issue of the Journal of Biomedical Sciences.

All diagnosed diabetics aged 12 years and over should have access to free, annual retinal screening, according to Diabetes UK's Your Vision awareness campaign.

Intravitreal bevacizumab (Avastin) can be beneficial in the treatment of severe retinopathy of prematurity (ROP), according to a study published in the July 2008 issue of the British Journal of Ophthalmology.

A refinement in the manufacturing of contact lens material has enabled scientists to build a contact lens with an integrated sensor than can detect changes in intraocular pressure (IOP), according to results published in the July 2008 issue of Advanced Functional Materials.

Bevacizumab (Avastin) has been shown to inhibit angiogenesis and growth of retinoblastoma, according to results of a study published in the July 2008 issue of the Archives of Ophthalmology.

A hydroxypropyl cellulose ophthalmic insert (Lacrisert, Aton Pharma) is a preservative-free product recommended for once-daily insertion in the inferior cul-de-sac. Its convenience, efficacy, and safety make it a valuable option for the management of dry eye disease.

Visual impairment is associated with an increased risk of suicide, according to results of a study published in the July 2008 issue of the Archives of Ophthalmology.

Bottles of timolol ophthalmic solution 0.25% and 0.5% (Sandoz Canada Inc.) have been recalled in Canada because of an increased risk of adverse events.